Acaluxen 100 mg (Acalabrutinib) is a Bruton’s tyrosine kinase (BTK) inhibitor used to treat certain blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. It works by blocking cancer cell growth. Common side effects include headache, fatigue, diarrhea, and an increased risk of infections. https://oncomedicure.com/product/acaluxen-100-mg-acalabrutinib/